nach oben

Virchows Archiv

Erschienen in:

26.05.2018 | Review and Perspectives

Hepatocellular nodules in vascular liver diseases

verfasst von: Christine Sempoux, Charles Balabaud, Valérie Paradis, Paulette Bioulac-Sage

Erschienen in: Virchows Archiv | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Hepatocellular nodules have been recognized in vascular liver diseases for a long time and mostly described and studied in the imaging literature. Some confusions in their identification and overlap in their definitions exist, especially in this specific clinical context. Pathology descriptions report the development of nodular regenerative hyperplasia, large regenerative nodule, and focal nodular hyperplasia, as adaptive responses of the liver parenchyma to the modified blood flow. True neoplastic hepatocellular nodules such as hepatocellular adenoma and hepatocellular carcinoma can also appear, mainly in Budd-Chiari syndrome, and have to be correctly diagnosed. This is more difficult for the radiologist in these diseased livers, leading more frequently to perform liver biopsies. We describe the histology of each type of well-differentiated hepatocellular nodules and provide some clues for their differential diagnosis. A review of the literature gives an historical perspective of the problem and enlightens the frequency and the subtypes of hepatocellular nodules found in the most common vascular liver diseases.

Bedossa P, Hytiroglou P, Yeh MM (2018) Vascular disorders. In: Burt AD, Ferrell LD, Hübscher SG (eds) MacSween’s pathology of the liver, 7th edn. Elsevier, Philadelphia, pp 636–672CrossRef

Vilgrain V, Paradis V, Van Wettere M, Valla D, Ronot M, Rautou PE (2018) Benign and malignant hepatocellular lesions in patients with vascular liver diseases. Abdom Radiol (NY). https://doi.org/10.1007/s00261-018-1502-7

Sempoux C, Paradis V, Komuta M, Wee A, Calderaro J, Balabaud C, Quaglia A, Bioulac-Sage P (2015) Hepatocellular nodules expressing markers of hepatocellular adenomas in Budd-Chiari syndrome and other rare hepatic vascular disorders. J Hepatol 63:1173–1180CrossRefPubMed

Ronot M, Vilgrain V (2014) Imaging of benign hepatocellular lesions: current concepts and recent updates. Clin Res Hepatol Gastroenterol 38:681–688CrossRefPubMed

Ueda T, Starkey J, Mori K, Fukunaga K, Shimofusa R, Motoori K, Minami M, Kondo F (2011) A pictorial review of benign hepatocellular nodular lesions: comprehensive radiological assessment incorporating the concept of anomalous portal tract syndrome. J Hepatobiliary Pancreat Sci 18:386–396CrossRefPubMed

Ferrell LD, Crawford JM, Dhillon AP, Scheuer PJ, Nakanuma Y (1993) Proposal for standardized criteria for the diagnosis of benign, borderline, and malignant hepatocellular lesions arising in chronic advanced liver disease. Am J Surg Pathol 117:1113–1123CrossRef

Wanless IR, International Working Party (1995) Terminology of nodular hepatocellular lesions. Hepatology 22:983–993CrossRef

Hytiroglou P, Theise ND (1998) Differential diagnosis of hepatocellular nodular lesions. Semin Diagn Pathol 15:285–299PubMed

Hytiroglou P (2017) Well-differentiated hepatocellular nodule: making a diagnosis on biopsy and resection specimens of patients with advanced stage chronic liver disease. Semin Diagn Pathol 34:138–145CrossRefPubMed

10.

EASL (2016) Clinical practice guidelines on the management of benign liver tumours. J Hepatol 65:386–398CrossRef

11.

Sannier A, Cazejust J, Lequoy M, Cervera P, Scatton O, Rosmorduc O, Wendum D (2016) Liver biopsy for diagnosis of presumed benign hepatocellular lesions lacking magnetic resonance imaging diagnostic features of focal nodular hyperplasia. Liver Int 36:1668–1676CrossRefPubMed

12.

Tanaka M, Wanless IR (1998) Pathology of the liver in Budd-Chiari syndrome: portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules. Hepatology 27:488–496CrossRefPubMed

13.

Vilgrain V, Lewin M, Vons C, Denys A, Valla D, Flejou JF, Belghiti J, Menu Y (1999) Hepatic nodules in Budd-Chiari syndrome: imaging features. Radiology 210:443–450CrossRefPubMed

14.

Zhou H, Wolff M, Pauleit D, Fischer HP, Pfeifer U (2000) Multiple macroregenerative nodules in liver cirrhosis due to Budd-Chiari syndrome. Case reports and review of the literature. Hepato-Gastroenterology 47:522–527PubMed

15.

Cazals-Hatem D, Vilgrain V, Genin P, Denninger MH, Durand F, Belghiti J, Valla D, Degott C (2003) Arterial and portal circulation and parenchymal changes in Budd-Chiari syndrome: a study in 17 explanted livers. Hepatology 37:510–519CrossRefPubMed

16.

Brancatelli G, Federle MP, Grazioli L, Golfieri R, Lencioni R (2002) Large regenerative nodules in Budd-Chiari syndrome and other vascular disorders of the liver: CT and MR imaging findings with clinicopathologic correlation. AJR Am J Roentgenol 178:877–883CrossRefPubMed

17.

Ibarrola C, Castellano VM, Colina F (2004) Focal hyperplastic hepatocellular nodules in hepatic venous outflow obstruction: a clinicopathological study of four patients and 24 nodules. Histopathology 44:172–179CrossRefPubMed

18.

Kobayashi S, Matsui O, Gabata T, Sanada J, Koda W, Minami T, Ryu Y (2009) Radiological and histopathological manifestations of hepatocellular nodular lesions concomitant with various congenital and acquired hepatic hemodynamic abnormalities. Jpn J Radiol 27:53–68CrossRefPubMed

19.

Park YN, Kojiro M, Di Tommaso L, Dhillon AP, Kondo F, Nakano M, Sakamoto M, Theise ND, Roncalli M (2007) Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules. Cancer 109:915–923CrossRefPubMed

20.

Pittman ME, Brunt EM (2015) Anatomic pathology of hepatocellular carcinoma: histopathology using classic and new diagnostic tools. Clin Liver Dis 19:239–259CrossRefPubMed

21.

Paradis V, Laurent A, Flejou JF, Vidaud M, Bedossa P (1997) Evidence for polyclonal nature of focal nodular hyperplasia of the liver by the study of X-chromosome inactivation. Hepatology 26:891–895CrossRefPubMed

22.

Wanless IR, Mawdsley C, Adams R (1985) On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 5:1194–1200CrossRefPubMed

23.

Paradis V, Bièche I, Dargère D, Laurendeau I, Nectoux J, Degott C, Belghiti J, Vidaud M, Bedossa P (2003) A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia. Gastroenterology 124:651–659CrossRefPubMed

24.

Rebouissou S, Couchy G, Libbrecht L, Balabaud C, Imbeaud S, Auffray C, Roskams T, Bioulac-Sage P, Zucman-Rossi J (2008) The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules. J Hepatol 49:61–71CrossRefPubMed

25.

Bioulac-Sage P, Laumonier H, Rullier A, Laumonier H, Rullier A, Cubel G, Laurent C, Zucman-Rossi J, Balabaud C (2009) Over-expression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology. Liver Int 29:459–465CrossRefPubMed

26.

Nault JC, Bioulac-Sage P, Zucman-Rossi J (2013) Hepatocellular benign tumors—from molecular classification to personalized clinical care. Gastroenterology 144:888–902CrossRefPubMed

27.

Rebouissou S, Franconi A, Calderaro J, Letouzé E, Imbeaud S, Pilati C, Nault JC, Couchy G, Laurent A, Balabaud C, Bioulac-Sage P, Zucman-Rossi J (2016) Genotype-phenotype correlation of CTNNB1mutations reveals different b-catenin activity associated with liver tumor progression. Hepatology 64:2047–2061CrossRefPubMed

28.

Bioulac-Sage P, Sempoux c BC (2017) Hepatocellular adenoma: classification, variants and clinical relevance. Semin Diagn Pathol 34:112–125CrossRefPubMed

29.

Saldarriaga J, Bisig B, Couchy G, Castain C, Zucman-Rossi J, Balabaud C, Sempoux C, Bioulac-Sage P (2017) Focal β-catenin mutation identified on formalin-fixed and paraffin-embedded inflammatory hepatocellular adenomas. Histopathology 71:989–993CrossRefPubMed

30.

Nault JC, Couchy G, Balabaud C, Morcrette G, Caruso S, Blanc JF, Bacq Y, Calderaro J, Paradis V, Ramos J, Scoazec JY, Gnemmi V, Sturm N, Guettier C, Fabre M, Savier E, Chiche L, Labrune P, Selves J, Wendum D, Pilati C, Laurent A, de Muret A, le Bail B, Rebouissou S, Imbeaud S, Bioulac-Sage P, Letouzé E, Zucman-Rossi J, Laurent C, Saric J, Frulio N, Castain C, Dujardin F, Benchellal Z, Bourlier P, Azoulay D, Luciani A, Pageaux GP, Fabre JM, Vilgrain V, Belghiti J, Bancel B, Boleslawski E, Letoublon C, Vaillant JC, Prévôt S, Castaing D, Jacquemin E, Peron JM, Quaglia A, Paye F, Terraciano L, Mazzaferro V, Saint Paul MC, Terris B (2017) Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation. Gastroenterology 152:880–894CrossRefPubMed

31.

Henriet E, Abou Hammoud A, Dupuy JW, Dartigues B, Ezzoukry Z, Dugot-Senant N, Leste-Lasserre T, Pallares-Lupon N, Nikolski M, Le Bail B, Blanc JF, Balabaud C, Bioulac-Sage P, Raymond AA, Saltel F (2017) Argininosuccinate synthase 1 (ASS1): a marker of unclassified hepatocellular adenoma and high bleeding risk. Hepatology 66:2016–2028CrossRefPubMed

32.

Agni RM (2017) Diagnostic histopathology of hepatocellular carcinoma: a case-based review. Semin Diagn Pathol 34:126–137CrossRefPubMed

33.

Choi WT, Ramachandran R, Kakar S (2017) Immunohistochemical approach for the diagnosis of a liver mass on small biopsy specimens. Hum Pathol 63:1–13CrossRefPubMed

34.

Shafizadeh N, Ferrell LD, Kakar S (2008) Utility and limitations of glypican-3 expression for the diagnosis of hepatocellular carcinoma at both ends of the differentiation spectrum. Mod Pathol 21:1011–1018CrossRefPubMed

35.

Di Tommaso L, Franchi G, Park YN, Fiamengo B, Destro A, Morenghi E, Montorsi M, Torzilli G, Tommasini M, Terracciano L, Tornillo L, Vecchione R, Roncalli M (2007) Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis. Hepatology 45:725–734CrossRefPubMed

36.

Ames JT, Federle MP, Chopra K (2009) Distinguishing clinical and imaging features of nodular regenerative hyperplasia and large regenerative nodules of the liver. Clin Radiol 64:1190–1195CrossRefPubMed

37.

Wang Y, Xue H, Jiang Q, Li K, Tian Y (2015) Multiple hyperplastic nodular lesions of the liver in the Budd-Chari syndrome: a case report and review of published reports. Ann Saudi Med 35:72–75CrossRefPubMed

38.

Kim H, Nahm JH, Park YN (2015) Budd-Chiari syndrome with multiple large regenerative nodules. Clin Mol Hepatol 21:89–94CrossRefPubMedPubMedCentral

39.

Putra J, Toor A, Noce TA, Thung SN, Suriawinata AA, Lisovsky M (2015) Multiple liver lesions in a patient with Budd-Chiari syndrome secondary to polycythemia vera. Ann Hepatol 14:547–549PubMed

40.

Liu FY, Wang MQ, Duan F, Fan QS, Song P, Wang Y (2013) Hepatocellular carcinoma associated with Budd-Chiari syndrome: imaging features and transcatheter arterial chemoembolization. BMC Gastroenterol 13:105CrossRefPubMedPubMedCentral

41.

Moucari R, Rautou PE, Cazals-Hatem D, Geara A, Bureau C, Consigny Y, Francoz C, Denninger MH, Vilgrain V, Belghiti J, Durand F, Valla D, Plessier A (2008) Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors. Gut 57:828–835CrossRefPubMed

42.

Gwon D 2nd, Ko GY, Yoon HK, Sung KB, Kim JH, Lee SS, Lee JM, Ohm JY, Shin JH, Song HY (2010) Hepatocellular carcinoma associated with membranous obstruction of the inferior vena cava: incidence, characteristics, and risk factors and clinical efficacy of TACE. Radiology 254:617–626CrossRefPubMed

43.

Ren W, Qi X, Yang Z, Han G, Fan D (2013) Prevalence and risk factors of hepatocellular carcinoma in Budd-Chiari syndrome: a systematic review. Eur J Gastroenterol Hepatol 25:830–841CrossRefPubMed

44.

Hilscher MB, Johnson JN, Cetta F, Driscoll DJ, Poterucha JJ, Sanchez W, Connolly HM, Kamath PS (2017) Surveillance for liver complications after the Fontan procedure. Congenit Heart Dis 12:124–132CrossRefPubMed

45.

Bryant T, Ahmad Z, Millward-Sadler H, Burney K, Stedman B, Kendall T, Vettukattil J, Haw M, Salmon AP, Cope R, Hacking N, Breen D, Sheron N, Veldtman GR (2011) Arterialised hepatic nodules in the Fontan circulation: hepatico-cardiac interactions. Int J Cardiol 15:268–272CrossRef

46.

Asrani SK, Asrani NS, Freese DK, Phillips SD, Warnes CA, Heimbach J, Kamath PS (2012) Congenital heart disease and the liver. Hepatology 56:1160–1169CrossRefPubMed

47.

Poterucha JT, Johnson JN, Qureshi MY, O'Leary PW, Kamath PS, Lennon RJ, Bonnichsen CR, Young PM, Venkatesh SK, Ehman RL, Gupta S, Smyrk TC, Dearani JA, Warnes CA, Cetta F (2015) Magnetic resonance elastography: a novel technique for the detection of hepatic fibrosis and hepatocellular carcinoma after the fontan operation. Mayo Clin Proc 90:882–894CrossRefPubMedPubMedCentral

48.

Oh C, Youn JK, Han JW, Kim GB, Kim HY, Jung SE (2016) Hepatocellular carcinoma after the Fontan procedure in a 16-year-old girl: a case report. Medicine (Baltimore) 95:e4823CrossRef

49.

Nandwana SB, Olaiya B, Cox K, Sahu A, Mittal P (2018) Abdominal imaging surveillance in adult patients after Fontan procedure: risk of chronic liver disease and hepatocellular carcinoma. Curr Probl Diagn Radiol 47:19–22CrossRefPubMed

50.

Takuma Y, Fukada Y, Iwadou S, Miyatake H, Uematsu S, Okamoto R, Sato D, Matsukawa H, Shiozaki S, Kamada M, Morito T, Araki Y (2016) Surgical resection for hepatocellular carcinoma with cardiac cirrhosis after the Fontan procedure. Intern Med 55:3265–3272CrossRefPubMedPubMedCentral

51.

Conroy MR, Moe TG (2017) Hepatocellular carcinoma in the adult Fontan patient. Cardiol Young 27:407–409CrossRefPubMed

52.

Josephus Jitta D, Wagenaar LJ, Mulder BJ, Guichelaar M, Bouman D, van Melle JP (2016) Three cases of hepatocellular carcinoma in Fontan patients: review of the literature and suggestions for hepatic screening. Int J Cardiol 206:21–26CrossRefPubMed

53.

Kwon S, Scovel L, Yeh M, Dorsey D, Dembo G, Krieger EV, Bakthavatsalam R, Park JO, Riggle KM, Riehle KJ, Yeung RS (2015) Surgical management of hepatocellular carcinoma after Fontan procedure. J Gastrointest Oncol 6:E55–E60PubMedPubMedCentral

54.

Elder RW, Parekh S, Book WM (2013) More on hepatocellular carcinoma after the Fontan procedure. N Engl J Med 369:490CrossRefPubMed

55.

Babaoglu K, Binnetoglu FK, Aydoğan A, Altun G, Gürbüz Y, Inan N, Corapçioğlu F (2010) Hepatic adenomatosis in a 7-year-old child treated earlier with a Fontan procedure. Pediatr Cardiol 31:861–864CrossRefPubMed

56.

Ghaferi AA, Hutchins GM (2005) Progression of liver pathology in patients undergoing the Fontan procedure: chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg 129:1348–1352CrossRefPubMed

57.

Bernard O, Franchi-Abella S, Branchereau S, Pariente D, Gauthier F, Jacquemin E (2012) Congenital portosystemic shunts in children: recognition, evaluation, and management. Semin Liver Dis 32:273–287CrossRefPubMed

58.

Blanc T, GuerinF, Franchi-Abella S, Jacquemin E, Pariente D, Soubrane O, Branchereau S, Gauthier F (2014) Congenital portosystemic shunts in children: a new anatomical classification correlated with surgical strategy. Ann Surg 260:188–198CrossRefPubMed

59.

Kanazawa H, Nosaka S, Miyazaki O, Sakamoto S, Fukuda A, Shigeta T, Nakazawa A, Kasahara M (2015) The classification based on intrahepatic portal system for congenital portosystemic shunts. J Pediatr Surg 50:688–695CrossRefPubMed

60.

Lisovsky M, Konstas AA, Misdraji J (2011) Congenital extrahepatic portosystemic shunts (Abernethy malformation): a histopathologic evaluation. Am J Surg Pathol 35:1381–1390CrossRefPubMed

61.

Pupulim LF, Vullierme MP, Paradis V, Valla D, Terraz S, Vilgrain V (2013) Congenital portosystemic shunts associated with liver tumours. Clin Radiol 68:e362–e369CrossRefPubMed

62.

Gülşen Z, Yiğit H, Demir P (2016) Multiple regenerative nodular hyperplasia in the left infrarenal vena cava accompanied by Abernethy malformation. Surg Radiol Anat 38:373–378CrossRefPubMed

63.

Hao Y, Hong X, Zhao X (2015) Congenital absence of the portal vein associated with focal nodular hyperplasia of the liver and congenital heart disease (Abernethy malformation): a case report and literature review. Oncol Lett 9:695–700CrossRefPubMed

64.

Osorio MJ, Bonow A, Bond GJ, Rivera MR, Vaughan KG, Shah A, Shneider BL (2011) Abernethy malformation complicated by hepatopulmonary syndrome and a liver mass successfully treated by liver transplantation. Pediatr Transplant 15:E149–E151CrossRefPubMed

65.

Sinakos E, Hytiroglou P, Chourmouzi D, Akriviadis E (2015) Focal nodular hyperplasia in an individual with Abernethy malformation type 1b. Dig Liver Dis 47:1089CrossRefPubMed

66.

Webster MW, Van Thiel DH, Bron KM, Barnes EL (1979) Hepatic adenoma associated with portasystemic shunting in a young woman. Digestion 19:328–334CrossRefPubMed

67.

Brasoveanu V, Ionescu MI, Grigorie R, Mihaila M, Bacalbasa N, Dumitru R, Herlea V, Iorgescu A, Tomescu D, Popescu I (2015) Living donor liver transplantation for unresectable liver adenomatosis associated with congenital absence of portal vein: a case report and literature review. Am J Case Rep 16:637–644CrossRefPubMedPubMedCentral

68.

Gordon-Burroughs S, Balogh J, Weiner MA, Monsour HP Jr, Schwartz MR, Gaber AO, Ghobrial RM (2014) Liver transplantation in an adult with adenomatosis and congenital absence of the portal vein: a case report. Transplant Proc 46:2418–2421CrossRefPubMed

69.

Arrivé L, Zucman-Rossi J, Balladur P, Wendum D (2016) Hepatocellular adenoma with malignant transformation in a patient with neonatal portal vein thrombosis. Hepatology 64:675–677CrossRefPubMed

70.

Tateishi Y, Furuya M, Kondo F, Torii I, Nojiri K, Tanaka Y, Umeda S, Okudela K, Inayama Y, Endo I, Ohashi K (2013) Hepatocyte nuclear factor-1 α inactivated hepatocellular adenomas in patient with congenital absence of the portal vein: a case report. Pathol Int 63:358–363CrossRefPubMed

71.

Handra-Luca A, Paradis V, Vilgrain V, Dubois S, Durand F, Belghiti J, Valla D, Degott C (2006) Multiple mixed adenoma-focal nodular hyperplasia of the liver associated with spontaneous intrahepatic porto-systemic shunt: a new type of vascular malformation associated with the multiple focal nodular hyperplasia syndrome? Histopathology 48:309–311CrossRefPubMed

72.

Sorkin T, Strautnieks S, Foskett P, Peddu P, Thompson RJ, Heaton N, Quaglia A (2016) Multiple β-catenin mutations in hepatocellular lesions arising in Abernethy malformation. Hum Pathol 53:153–158CrossRefPubMed

73.

Franchi-Abella S, Branchereau S, Lambert V, Fabre M, Steimberg C, Losay J, Riou JY, Pariente D, Gauthier F, Jacquemin E, Bernard O (2010) Complications of congenital portosystemic shunts in children: therapeutic options and outcomes. J Pediatr Gastroenterol Nutr 51:322–330PubMed

74.

Benedict M, Rodriguez-Davalos M, Emre S, Walther Z, Morotti R (2017) Congenital extrahepatic portosystemic shunt (Abernethy malformation type Ib) with associated hepatocellular carcinoma: case report and literature review. Pediatr Dev Pathol 20:354–362CrossRefPubMed

75.

Sharma R, Suddle A, Quaglia A, Peddu P, Karani J, Satyadas T, Heaton N (2015) Congenital extrahepatic portosystemic shunt complicated by the development of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 14:552–557CrossRefPubMed

76.

Lautz TB, Shah SA, Superina RA (2016) Hepatoblastoma in children with congenital portosystemic shunts. J Pediatr Gastroenterol Nutr 62:542–545CrossRefPubMed

77.

Cazals-Hatem D, Hillaire S, Rudler M, Plessier A, Paradis V, Condat B, Francoz C, Denninger MH, Durand F, Bedossa P, Valla DC (2011) Obliterative portal venopathy: portal hypertension is not always present at diagnosis. J Hepatol 54:455–461CrossRefPubMed

78.

Guido M, Sarcognato S, Sonzogni A, Lucà MG, Senzolo M, Fagiuoli S, Ferrarese A, Pizzi M, Giacomelli L, Colloredo G (2016) Obliterative portal venopathy without portal hypertension: an underestimated condition. Liver Int 36:454–460CrossRefPubMed

79.

Lee H, Rehman AU, Fiel MI (2016) Idiopathic noncirrhotic portal hypertension: an appraisal. J Pathol Transl Med 50:17–25CrossRefPubMed

80.

Glatard AS, Hillaire S, d'Assignies G, Cazals-Hatem D, Plessier A, Valla DC, Vilgrain V (2012) Obliterative portal venopathy: findings at CT imaging. Radiology 263:741–750CrossRefPubMed

81.

Sugimoto K, Kondo F, Furuichi Y, Oshiro H, Nagao T, Saito K, Yoshida H, Imai Y, Fukusato T, Moriyasu F (2014) Focal nodular hyperplasia-like lesion of the liver with focal adenoma features associated with idiopathic portal hypertension. Hepatol Res 44:E309–E315CrossRefPubMed

82.

Franchi-Abella S, Fabre M, Mselati E, De Marsillac ME, Bayari M, Pariente D, Jacquemin E, Bernard O (2014) Obliterative portal venopathy: a study of 48 children. J Pediatr 165:190–193.e2CrossRefPubMed

83.

Garcia-Tsao G, Korzenik JR, Young L, Henderson KJ, Jain D, Byrd B, Pollak JS, White RI Jr (2000) Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 343:931–936CrossRefPubMed

84.

Brenard R, Chapaux X, Deltenre P, Henrion J, De Maeght S, Horsmans Y, Borbath I, Leenaerts A, Van Cauter J, Francque S, Sersté T, Moreno C, Orlent H, Mengeot P, Lerut J, Sempoux C (2010) Large spectrum of liver vascular lesions including high prevalence of focal nodular hyperplasia in patients with hereditary haemorrhagic telangiectasia: the Belgian registry based on 30 patients. Eur J Gastroenterol Hepatol 22:1253–1259CrossRefPubMed

85.

Scardapane A, Ficco M, Sabbà C, Lorusso F, Moschetta M, Maggialetti N, Suppressa P, Angelelli G, Stabile Ianora AA (2013) Hepatic nodular regenerative lesions in patients with hereditary haemorrhagic telangiectasia: computed tomography and magnetic resonance findings. Radiol Med 118:1–13CrossRefPubMed

86.

Wanless IR, Gryfe A (1986) Nodular transformation of the liver in hereditary hemorrhagic telangiectasia. Arch Pathol Lab Med 110:331–335PubMed

87.

Shimoyama Y, Kakizaki S, Katano A, Takakusaki S, Mizuide M, Ichikawa T, Sato K, Takagi H, Mori M (2009) Hereditary hemorrhagic telangiectasia with multiple hepatic and pulmonary nodular lesions. Clin J Gastroenterol 2:131–136CrossRefPubMed

88.

Dissanayake R, Wickramarathne KP, Seneviratne SN, Perera SN, Fernando MU, Wickramasinghe VP (2017) Hereditary hemorrhagic telangiectasia, liver disease and elevated serum testosterone (Osler-Weber-Rendu syndrome): a case report. BMC Res Notes 10:58CrossRefPubMedPubMedCentral

89.

Quaglia A, Jutand MA, Dhillon A, Godfrey A, Togni R, Bioulac-Sage P, Balabaud C, Winnock M, Dhillon AP (2005) Classification tool for the systematic histological assessment of hepatocellular carcinoma, macroregenerative nodules, and dysplastic nodules in cirrhotic liver. World J Gastroenterol 1140:6262–6268CrossRef

90.

Sasaki M, Yoneda N, Kitamura S, Sato Y, Nakanuma Y (2012) A serum amyloid A-positive hepatocellular neoplasm arising in alcoholic cirrhosis: a previously unrecognized type of inflammatory hepatocellular tumor. Mod Pathol 25:1584–1593CrossRefPubMed

91.

Sasaki M, Kondo F, Sawai Y, Imai Y, Kadowaki S, Sano K, Fukusato T, Matsui O, Nakanuma Y (2013) Serum amyloid A-positive hepatocellular neoplasms in the resected livers from 3 patients with alcoholic cirrhosis. Histol Histopathol 2:1499–1505

92.

Calderaro J, Nault JC, Balabaud C, Couchy G, Saint-Paul MC, Azoulay D, Mehdaoui D, Luciani A, Zafrani ES, Bioulac-Sage P, Zucman-Rossi J (2016) Inflammatory hepatocellular adenomas developed in the setting of chronic liver disease and cirrhosis. Mod Pathol 29:43–50CrossRefPubMed

93.

Gordic S, Thung SN, Roayaie S, Wagner M, Taouli B (2017) Hepatic adenomatosis in liver cirrhosis. Eur J Radiol Open 4:115–117CrossRefPubMedPubMedCentral

94.

Hubert C, Sempoux C, Horsmans Y, Rahier J, Humblet Y, Machiels JP, Ceratti A, Canon JL, Gigot JF (2007) Nodular regenerative hyperplasia: a deleterious consequence of chemotherapy for colorectal liver metastases? Liver Int 27:938–943CrossRefPubMed

95.

Rubia-Brandt L, Lauwers GY, Wang H, Majno PE, Tanabe K, Zhu AX, Brezault C, Soubrane O, Abdalla EK, Vauthey JN, Mentha G, Terris B (2010) Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology 56:430–439CrossRef

96.

Vigano L, Rubbia-Brandt L, De Rosa G, Majno P, Langella S, Toso C, Mentha G, Capussotti L (2015) Nodular regenerative hyperplasia in patients undergoing liver resection for colorectal metastases after chemotherapy: risk factors, preoperative assessment and clinical impact. Ann Surg Oncol 22:4149–4157CrossRefPubMed

97.

Paradis V, Bioulac-Sage P, Balabaud C (2014) Congenital hepatic fibrosis with multiple HNF1α hepatocellular adenomas. Clin Res Hepatol Gastroenterol 38:e115–e116CrossRefPubMed

98.

Roncalli M, Maggioni M, Opocher E, Coggi G (1999) Development of a high grade dysplastic nodule in a case of congenital hepatic fibrosis. Ital J Gastroenterol Hepatol 31:301–330PubMed

99.

Sanada Y, Mizuta K, Niki T, Tashiro M, Hirata Y, Okada N, Yamada N, Ihara Y, Urahashi T, Soejima Y, Fukusato T, Kondo F (2015) Hepatocellular nodules resulting from congenital extrahepatic portosystemic shunts can differentiate into potentially malignant hepatocellular adenomas. J Hepatobiliary Pancreat Sci 22:746–756CrossRefPubMed

100.

Le Bail B, Chiche L, Balabaud C, Bioulac-Sage P (2018) Collision of hepatocellular nodules in vascular livers: a medical challenge. Clin Res Hepatol Gastroenterol (in press)

101.

Nault JC, Mallet M, Pilati C, Nault JC, Mallet M, Pilati C, Calderaro J, Bioulac-Sage P, Laurent C, Laurent A, Cherqui D, Balabaud C, Zucman-Rossi J (2013) High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions. Nat Commun 4:2218CrossRefPubMedPubMedCentral

Titel: Hepatocellular nodules in vascular liver diseases
verfasst von: Christine Sempoux
Charles Balabaud
Valérie Paradis
Paulette Bioulac-Sage
Publikationsdatum: 26.05.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Virchows Archiv / Ausgabe 1/2018
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI: https://doi.org/10.1007/s00428-018-2373-6

Neu im Fachgebiet Pathologie

01.04.2024 | Forensische Traumatologie | CME

Springer Medizin

Hepatocellular nodules in vascular liver diseases

Abstract

Neu im Fachgebiet Pathologie

Theoretische Grundlagen von Explosionen und Explosionsverletzungen

Auswirkungen vorgeschalteter Laborprozesse auf die Digitalisierung histologischer Schnittpräparate

Knochenmarkhistologie bei Zytopenien

Herausforderungen der Automation bei der quantitativen Auswertung von Leberbiopsien

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2018

Predominantly cystic clear cell renal cell carcinoma and multilocular cystic renal neoplasm of low malignant potential form a low-grade spectrum

Primary adrenal diffuse large B cell lymphoma: a clinicopathological and molecular study from China

Chondroid nodule in the female peritoneum arises from normal tissue and not from teratoma or conception product

Regression of human cirrhosis: an update, 18 years after the pioneering article by Wanless et al.

Vascular liver diseases on the clinical side: definitions and diagnosis, new concepts

Molecular evidence of JAK2 p.V617F mutated pure erythroid leukemia arising from polycythemia vera

Neu im Fachgebiet Pathologie

Theoretische Grundlagen von Explosionen und Explosionsverletzungen

Auswirkungen vorgeschalteter Laborprozesse auf die Digitalisierung histologischer Schnittpräparate

Knochenmarkhistologie bei Zytopenien

Herausforderungen der Automation bei der quantitativen Auswertung von Leberbiopsien